Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 3/20 | 0.33 |
| ▸ | CPT2 | P23786 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1129741 | 0.97 | ALDH1A1 (0.42) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Ammonia Solution, Strong SCHEMBL11776041 | 0.95 | ALDH1A1 (0.40) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL28489478 | 0.95 | ALDH1A1 (0.40) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL10887081 | 0.84 | ALDH1A1 (0.36) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL6634867 | 0.72 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1 | |
| SCHEMBL6561842 | 0.72 | ALDH1A1 (0.42) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL6570219 | 0.70 | ALDH1A1 (0.46) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Citric Acid SCHEMBL27680154 | 0.70 | ALDH1A1 (0.75) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Citric Acid SCHEMBL5464340 | 0.70 | ALDH1A1 (0.75) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL18798923 | 0.70 | ACLY (0.38) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9118062-B2 | Anode and method of manufacturing the same, and battery and method of manufacturing the same | SONY CORPORATION (JP) | 2015-08-25 | — | — | US | claimed |
| US-RE45310-E1 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2014-12-30 | — | — | US | claimed |
| US-20080311472-A1 | ANODE AND METHOD OF MANUFACTURING THE SAME, AND BATTERY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2008-12-18 | — | — | US | claimed |
| US-9118062-B2 | Anode and method of manufacturing the same, and battery and method of manufacturing the same | SONY CORPORATION (JP) | 2015-08-25 | — | — | US | disclosed |
| US-RE45310-E1 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8377589-B2 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8349489-B2 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-20120231335-A1 | CATHODE ACTIVE MATERIAL, CATHODE THEREWITH AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SONY CORPORATION (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20110250509-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | SONY CORPORATION (JP) | 2011-10-13 | — | — | US | disclosed |
| US-20090202905-A1 | CATHODE ACTIVE MATERIAL, CATHODE THEREWITH AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SONY CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090169985-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20080311472-A1 | ANODE AND METHOD OF MANUFACTURING THE SAME, AND BATTERY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090169985-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | CA12, CA1, STS | ALDH1A1 502/4885CYP2D6 2865/4885TSHR 3173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.